Intracerebral haemorrhage is inadequately controlled by current treatments, requiring new
solutions to improve the prognosis. Following the primary injury, a proinflammatory cascade …

Minocycline is a second‐generation, semi‐synthetic tetracycline that has been in therapeutic
use for over 30 years because of its antibiotic properties against both gram‐positive and …

Axonal regeneration and formation of tripartite (axo-glial) junctions at damaged sites is a
prerequisite for early repair of injured spinal cord. Transplantation of stem cells at such sites …

Research on matrix metalloproteinases (MMPs) and in particular on gelatinase B, alias MMP-
9, has grown exponentially in the decade 2003–2012. Structural details about flexibility of …

Intracerebral hemorrhage (ICH) is one of the most lethal stroke subtypes. Despite the high
morbidity and mortality associated with ICH, its pathophysiology has not been investigated …

Intracerebral hemorrhage (ICH) is a subtype of stroke with high mortality and disability but
no specific or effective treatment. In the last two decades, much has been learned about the …

The prognosis of intracerebral haemorrhage continues to be devastating despite much
research into this condition. A prominent feature of intracerebral haemorrhage is …

Stroke is the second highest cause of death globally, with an increasing incidence in
developing countries. Intracerebral hemorrhage (ICH) accounts for 10–15% of all strokes …

Objective Intracerebral hemorrhage (ICH) is the most lethal subtype of stroke, without
effective treatment. Necrosulfonamide (NSA), a specific inhibitor for mixed lineage kinase …

Many mechanisms contribute to the secondary injury cascades following traumatic spinal
cord injury (SCI). However, most current treatment strategies only target one or a few …